Moraxella atlantae bacteraemia in a patient with systemic lupus erythematosis.
We describe the first reported case of human infection caused by Moraxella atlantae (formerly known as CDC group M-3) and its successful treatment with intravenous cefuroxime. The isolation and identification of this species, as well as the pathogenesis of the infection, are discussed. It is recommended that isolates of Moraxella species be speciated so that the epidemiological characteristics and pathogenesis of the infections caused by the various species may be understood more completely.